Вы находитесь на странице: 1из 18

SEQ 0017 JOB PDF8280-000-007 PAGE-0001 PRELIMS I-X1V

REVISED 04DEC01 AT 13:45 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Clinical Data Management, 2nd Edition. Richard K. Rondel, Sheila A. Varley, Colin F. Webb
Copyright 1993, 2000 John Wiley & Sons Ltd
ISBNs: 0471-98329-2 (Hardback); 0470-84636-4 (Electronic)

Clinical Data
Management
SECOND EDITION
SEQ 0003 JOB WIL8280-000-007 PAGE-0003 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Clinical Data
Management
SECOND EDITION
Edited by

RICHARD K. RONDEL
University of Surrey, UK

SHEILA A. VARLEY
Quintiles (UK) Ltd. Berkshire, UK

COLIN F. WEBB
Amgen Ltd, Cambridge, UK

JOHN WILEY & SONS, LTD


Chichester . New York . Weinheim . Brisbane . Singapore . Toronto
SEQ 0004 JOB WIL8280-000-007 PAGE-0004 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

First published 1993 (reprinted 1994; 1995, twice; 1996; 1998, twice), Second Edition
published 2000
Copyright 1993, 2000 by John Wiley & Sons Ltd,
Baffins Lane, Chichester,
West Sussex PO19 1UD, England
National 01243 779777
International (+44) 1243 779777
e-mail (for orders and customer service enquiries):
cs-books@wiley.co.uk
Visit our Home Page on http://www.wiley.co.uk
or http://www.wiley.com
All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval
system, or transmitted, in any form or by any means, electronic, mechanical, photocopying,
recording, scanning or otherwise, except under the terms of the Copyright, Designs and
Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency,
90 Tottenham Court Road, London, UK W1P 9HE, without the permission in writing of the
publisher.
Other Wiley Editorial Offices
John Wiley & Sons, Inc., 605 Third Avenue,
New York, NY 10158-0012, USA
WILEY-VCH Verlag GmbH, Pappelallee 3,
D-69469 Weinheim, Germany
Jacaranda Wiley Ltd, 33 Park Road, Milton,
Queensland 4064, Australia
John Wiley & Sons (Asia) Pte Ltd, 2 Clementi Loop #02-01,
Jin Xing Distripark, Singapore 129809
John Wiley & Sons (Canada) Ltd, 22 Worcester Road,
Rexdale, Ontario M9W 1L1, Canada
Library of Congress Cataloging-in-Publication Data
Clinical data management / edited by Richard K. Rondel, Sheila A. Varley,
Colin F. Webb. 2nd ed.
p. cm.
Includes bibliographical references and index.
ISBN 0-471-98329-2 (cased)
1. MedicineResearchData processing. I. Rondel, R. K.
II. Varley, S. A.
[DNLM: 1. Information Systems. 2. Automatic Data Processing.
3. Data Collection. 4. Data Display. 5. Quality Control. W
26.55.I4 C641 1999]
R853.D37C55 1999
610'.285dc21
DNLM/DLC
for Library of Congress 9931926
CIP
British Library Cataloguing in Publication Data
A catalogue record for this book is available from the British Library
ISBN 0-471-98329-2
Typeset in 10/12pt Cheltenham Book by Dorwyn Ltd, Rowlands Castle, Hants.
Printed and bound in Great Britain by Biddles Ltd, Guildford and Kings Lynn
This book is printed on acid-free paper responsibly manufactured from sustainable
forestry, in which at least two trees are planted for each one used for paper production.
SEQ 0005 JOB WIL8280-000-007 PAGE-0005 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Contents

Contributors vii

Foreword xi

Preface xiii

1 Chapter Review 1
Stuart W. Cummings

2 The International Conference on Harmonisation and its Impact 21


Beverley Smith and Linda Heywood

3 Case Report Form Design 47


Moura Avey

4 Data Capture 75
Emma Waterfield

5 Planning and Implementation 89


Chris Thomas

6 Data Validation 109


Pankaj Panni Patel

7 Quality Assurance and Clinical Data Management 123


Heather Campbell and John Sweatman

8 Performance Measures 143


Jon Wood

9 Data Presentation 159


Munish Mehra

10 Coding of DataMedDRA and other Medical Terminologies 177


Elliot G. Brown and Louise Wood

11 Database Design Issues for Central Laboratories 207


Tom Tollenaere
SEQ 0006 JOB WIL8280-000-007 PAGE-0006 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

vi CONTENTS

12 Computer Systems 229


Louise Palma

13 Systems Software Validation IssuesClinical Trials Database


Environment 249
Steve Hutson

14 Re-engineering the Clinical Data Management Process 271


Steve Arlington, Paul Athey, John Carroll and Alistair Shearin

15 Working with Contract Research Organizations 293


Kenneth Buchholz

16 Data Management in Epidemiology and Pharmacoeconomics 307


Michael F. Ryan and Andreas M. Pleil

17 Future Revisited 325


Ruth Lane

Index 347
SEQ 0007 JOB WIL8280-000-007 PAGE-0007 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Contributors

Steve Arlington
PricewaterhouseCoopers, West London Office, Harman House, 1 George
Street, Uxbridge, London UB1 1QQ, UK

Paul Athey
PricewaterhouseCoopers, West London Office, Harman House, 1 George
Street, Uxbridge, London UB1 1QQ, UK

Moira Avey
2 Loughton Villas, Crowborough, East Sussex TN6 5UD, UK

Elliot G. Brown
EBC Ltd, 7 Woodfall Avenue, High Barnet, Herts EN5 2EZ, UK

Kenneth Buchholz
INC Research, Charlottesville, Virginia, USA

Heather Campbell
Covance Clinical & Periapproval Services Ltd, 7 Roxborough Way,
Maidenhead, Berkshire S16 3UD, UK

John Carroll
PricewaterhouseCoopers, West London Office, Harman House, 1 George
Street, Uxbridge, London UB1 1QQ, UK

Stuart W. Cummings
Merck Sharp & Dohme (Europe), Inc., Clos du Lynx 5, Lynx Binnenhof,
Brussel 1200, Bruxelles, Belgium

Linda Heywood
Amgen Ltd, 240 Cambridge Science Park, Milton Road, Cambridge CB4 0WD,
UK

Steve Hutson
Barnett International, Parexel, River Court, 50 Oxford Road, Denham,
Middlesex, UB9 49L, UK
SEQ 0008 JOB WIL8280-000-007 PAGE-0008 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

viii CONTRIBUTORS

Ruth Lane
MDS Therapeutic Director, Glaxo Wellcome UK, Greenford Road, Greenford,
Middlesex UB6 0HE, UK

Munish Mehra
M2 Worldwide, 1401 Rockville Pike, Suite 300, Rockville, Maryland 20852,
USA

Louise Palma
Berlex Laboratories Inc., 340 Changebridge Road, PO Box 1000, Montville,
New Jersey 07045-1000, USA

Pankaj Panni Patel


Manager, Contract Operations and Resource Management, SmithKline
Beecham Pharmaceuticals, New Frontiers Science Park (South), Third
Avenue, Harlow, Essex CM19 5AW, UK

Andreas M. Pleil
Pharmacia & Upjohn AB, Lindhagensgatan 133, S-112 87 Stockholm, Sweden

Richard K. Rondel
HPRU Medical Research Centre, University of Surrey, Egerton Road,
Guildford, Surrey GU2 5XP, UK

Michael F. Ryan
460 Foothill Road, Bridgewater, New Jersey 08807, USA

Alistair Shearin
PricewaterhouseCoopers, West London Office, Harman House, 1 George
Street, Uxbridge, London, UB1 1QQ, UK

Beverley Smith
Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California
91320-1789, USA

John Sweatman
7 Fox Covert, Lightwater, Surrey GU18 5TU, UK

Chris Thomas
Covance Clinical & Periapproval Services Ltd, 7 Roxborough Way,
Maidenhead, Berkshire S16 3UD, UK
SEQ 0009 JOB WIL8280-000-007 PAGE-0009 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

CONTRIBUTORS ix
Tom Tollenaere
T2 Data Consult BVBA, Willemstraat 28, B-3000 Leuven, Belgium

Sheila A. Varley
Customer Strategic Business Unit, Drug Development Services, Clinical
Services Europe, Quintiles Ltd, Ringside, 79 High Street, Bracknell, Berkshire
RG12 1DZ, UK

Emma Waterfield
Clinical Trials Research Ltd, 107/123 King Street, Maidenhead, Berkshire
SL6 1DP, UK

Colin F. Webb
Amgen Ltd, 240 Cambridge Science Park, Milton Road, Cambridge CB4 4WD,
UK

Jon Wood
Phoenix International UK, Mildmay House, St Edwards Court, London Road,
Romford, Essex RM7 9QD, UK

Louise Wood
Epidemiology Unit, Post Licensing Division, Medicines Control Agency,
Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK
SEQ 0011 JOB WIL8280-000-007 PAGE-0011 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Foreword

Clinical data management is a profession with increasing importance


within pharmaceutical research and development. The diverse lineage of
clinical data management coupled with a wide range of responsibilities
makes a clear, clean definition of clinical data management difficult at
best. As complex and diverse as the profession is, it is a field in which the
number of substantial publications is extremely small. The first edition of
this book provided one of the very few in-depth resources for clinical data
management professionals. This second edition continues in that tradition
by expanding and updating that knowledgebase.
Authored by professionals on both sides of the Atlantic, this text is
reflective of the current trends of global harmonisation of clinical research
and development. With the global consolidation of the industry, it is crit-
ical to understand, appreciate and be able to work within the framework of
global clinical development. This text should contribute to that
understanding.
As the global clinical data management discipline continues to grow we
can rightfully expect an increase in the amount of research and reference
material, such as this book, available to those working in and around the
pharmaceutical industry. This is good for all involvedauthors, pub-
lishers and readers!

Paul R. Loughlin
Chairperson,
Association for Clinical Data Management (ACDM)
Dr Kenneth Buchholz
Chairman of the Board of Trustees
Society for Clinical Data Management
SEQ 0013 JOB WIL8280-000-007 PAGE-0013 PRELIMS I-X1V
REVISED 01NOV99 AT 18:21 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Preface

Clinical Data Management has come a long way in the last decade. It is now
a firmly established discipline in its own right, and is becoming an area
that people know about and can progress their careers within.
We feel that the next decade will see major changes with the advantage
of electronic data capture. The clinical and data jobs/disciplines as we
know them today will become one as companies use more and more
sophisticated hardware and software to streamline and eliminate duplica-
tion from the clinical trial process. Gone will be the days of the Investiga-
tor giving the CRF to CRA, CRA giving the CRF to DM, DM giving the CRF to
DE. DE enters it, gives CRF back to DM and so on.
The ever increasing computerisation of the worldwide healthcare sys-
tem will mean a practically paperless environment when study protocols
will specify what data points at which intervals need to be transmitted
from the clinic to the company headquarters via electronic means.
The need will then be for strict computer validation to audit trail data
edits, electronic querying of data and mechanisms to ensure the host
database at the hospital site is updated correctly and not corrupted.
The industry is still contracting, with more and more mergers and aqui-
sitions occurring daily. The world of Contract Research Organisations has
started to follow, with CROs, often of considerable size, going through
takeovers and mergers to supply the type and size of service that the new
emerging pharmaceutical companies need. We are seeing the emergence
of virtual pharmaceutical/biotechnology companies who have no inten-
tion of having their own clinical research staff, but who just buy in a drug
and then rely on the service industry to take it to the market place.
We predict that the top pharma/CRO companies today will not be the
players of tomorrow unless they now address the necessary structures
and technology to move themselves into the New Tomorrow, and the true
advent of electronic data capture.

RKR
SAV
CFW
SEQ 0003 JOB PDF8280-400-006 PAGE-0347 INDEX 347-354
REVISED 30NOV01 AT 16:35 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

Clinical Data Management, 2nd Edition. Richard K. Rondel, Sheila A. Varley, Colin F. Webb
Copyright 1993, 2000 John Wiley & Sons Ltd
ISBNs: 0471-98329-2 (Hardback); 0470-84636-4 (Electronic)

Index

Abbreviated NDA (ANDA) 161 Case-control studies 314


ADROIT 187 Central laboratories, database
Adverse drug events (ADEs) 100, 165, design 20728
169, 308, 310, 314, 317 CIOMS process 18, 311
by treatment group 175 Clean databases 2267
Adverse drug reactions (ADRs) 178, CLINflo Version 2 2424
180, 187 Clinical data, types 1646
reporting program 310 Clinical Data Management (CDM) 15,
terminology 181 2642, 75, 76, 79, 81, 82, 87
Adverse Event Reporting System data validation 11119
(AERS) database 200 future 1819, 32645
Aggregate data 167 primary objective
to identify outliers 171 quality assurance 11920, 12341
AlmediFAX 244 future 13940
Alphanumeric codes for missing requirement in GCP 109
values 221 training 1356
Assessment 105 see also Data management
Audit trails 2227 Clinical research, issues for the
comparison of designs 2256 90s 2734
design approaches 2235 Clinical study reports, content and
Audits 8, 12535, 138, 140 structure 323
certificates 135 Clinical Trial Management System
clinical study (CTMS) 1489
computerised system 2545 Clinical trials
data 1313 computer systems in 3940
data management 130 design 336
definition 125 general considerations 289
documentation 1301 statistical considerations 336
figures 1334 Clintrial Version 4 database
investigator site 12730 system 234
key variables 132 Coding of data 1011, 132, 133, 146,
listings 1334 177205
process 138 need for 1789
QA 132, 133 problems 17981
tables 1334 Coding System for a Thesaurus of
Adverse Reaction Terms. See
Billing records 3201 COSTART
Biologic Licence Application (BLA), Cohort studies 316
electronic format 41 Communication
British Association for Research extension 328, 3402
Quality Assurance (BARQA) 127 re-engineering 290
Compliance Program Guidance Manuals
Case Report Form. See CRF 123
Case Report Tabulations (CRTs), Computer Assisted New Drug
electronic submission 42 Application (CANDA) 156, 331
SEQ 0308 JOB WIL8280-400-005 PAGE-0348 INDEX 347-354
REVISED 11NOV99 AT 15:23 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

348 INDEX

Computer Assisted Product Licence therapeutic, regulatory or functional


Application (CAPLA) 331, 332 expertise 295
Computer systems 1213, 22947 up-front investment of time and
analysis and testing 2323 resources 3001
applicable guidelines and work environment 297
regulations 208 Cost-benefit analyses 310
audit 2545 Cost-effectiveness analyses (CEA) 309
benefits of new processes and Cost-minimisation analyses 309
technologies 22930 Cost-of-illness studies 309
definition 252 Cost-of-treatment studies 309
development of clinical Cost-utility analyses 310
systems 234 COSTART 132, 180, 1823, 188, 202
establishing evaluation Council of International Organisations
criteria 2302 of Medical Science (CIOMS) 18,
evaluation of commercial 311
systems 23445 CRF 6, 7, 4773, 76, 77, 79, 81, 82, 96,
in clinical trials 3940 101, 109, 123, 128, 234
overall objectives 2301 analogue scales 601
prospective validation 260 data collection 524
retrospective validation Age datum 534
25760 precision 53
technical criteria 2312 data duplication 71
testing 2612 definition 47
validation 250, 254, 261 design 23, 5168, 118, 320, 321
verification 2601 closed response 5660
Computer validation 139 combination of open and closed
Construct validity 318 response 60
Content validity 318 content 524
Contract Research Organisations diary cards 623
(CROs) 1617, 75, 91, 101, 113, house style 648
273, 293305, 342 matrices 59
access to additional sites/ methodology 638
patients 295 open response 546
contract details 299301 presentation 5463
contract group 300 wording 612
delivery dates 299300 electronic format 42, 82, 331, 333
disaster recovery 2989 function 478
expectations 299 library 72
new approaches in working life history 48
relationships 3034 missing data 118, 212
price considerations 301 mock-up 68
procedures 2978 production 6870
quality considerations 2956 protocol 4851, 93
quality standards 300 review meetings and version
reasons for working with 2945 control 51
Request for Proposal (RFP) 296 review 72
role as supplemental staff 2945 standard modules 702
selection considerations 2959 tabulations (CRT) 167
sponsor relationship with 3013 time and event schedule 501
staff resources 296 workflow systems 23944
systems validation and CRF-Documetrix 23941
compliance 297 CRFTrack 2412
SEQ 0229 JOB WIL8280-400-004 PAGE-0349 IMPORT
REVISED 05NOV99 AT 13:45 BY IG DEPTH: 58.01 PICAS WIDTH 40 PICAS

INDEX 349
Criterion validity 318 Data normalisation 207
Culture evolution 328, 3445 Data presentation 910, 15976
Cycle times 1503 analysis 171
categorising schemata 164
Data audits 1313 clinical research issues 1602
Data capture 34, 7587 general issues 1624
automated data acquisition from poorly designed 163
optical images 802 quality assurance 171
background 76 raw data 1667, 170
choice of method 845 samples 1726
electronic 329 summary data 1679
electronic diaries 84 validation 1701
fax-based 7980 well-designed 164
future prospects 857 Data Protection 338
medical records 86 Data quality 31719
remote, via Internet 856 as performance measure 14950
remote electronic 138 factors affecting 11819
single/double data entry 767 Data retrieval, MedDRA 1958
smart cards 87 Data sourcing
traditional methods 769 epidemiologic studies 31012
Data Clarification Form (DCF) 241 pharmacoeconomic studies 31012
Data coding. See Coding of data Data structures, testing 233
Data collection 1445 Data transfer, electronic 156
alternatives 234 Data validation 67, 10919, 146
role of data manager 3202 CDM 11119
Data corrections 2227 during clinical trial 11019
system requirements 2225 future 1201
Data duplication 71 investigator 110
Data entry 99, 145 monitor 11011
centralised vs local 789 see also Validation
MedDRA 1945 Databases
remote (RDE) 4, 824, 2389 avoiding enforced uniqueness
screen design 778 21718
Data entry systems 4 clean 2267
Data flow diagram 989 Clintrial version 4 2346
Data handling 21318 design 1112, 166, 209
unexpected results 21920 central laboratories 20728
Data inconsistencies 21013 unexpected results 21822
Data integrity 31719 DLB Recorder 2367
Data listings 167, 170 editing 146
Data management 143, 274 exploiting 3278
audits 130 ideal 318
details 94 new releases 234
epidemiology 3078 normalisation 20913
pharmacoeconomics 30810 normalisation and inconsistent
pre-initiation activities 320 data 21013
project team 102 normalised vs denormalised 162
strategies 344 primary data and sources 311
technology in 32734 QOST 312
see also Clinical Data Management validation, case study 2637
(CDM) Date conventions 119
Data managers, challenges facing 328 Decommissioning 256
SEQ 0230 JOB WIL8280-400-004 PAGE-0350 IMPORT
REVISED 05NOV99 AT 13:45 BY IG DEPTH: 58.01 PICAS WIDTH 40 PICAS

350 INDEX

Definitions for expedited Electronic laboratory data 119


reporting 312 Electronic mail 100
Demographics by treatment Electronic packages 139
group 173, 174 Electronic records 389
Descriptive statistics 169 Electronic signatures 389, 139
Descriptive studies 314 E-mail addresses 43
Diary cards 623 Emerging markets 328, 345
Dictionary coding 97 Enforcement Policy 39
Disaster recovery 2989 Epidemiology 1718
Discriminant validity 318 data integrity and quality 31719
DLB Recorder database management data management 3078
system 2367 data sourcing
Document Management Systems 234 study validity 31719
Documentation 95, 132, 256 Error metrics 135
audits 1301 Establishment Licence Application
system development life cycle model (ELA), electronic format 41
(SDLC) 262 European Agency for the Evaluation of
validation 261, 2689 Medicinal Products (EMEA) 160,
Drug Information Association 200, 338
(DIA) 127 European Union (EU) directive 367
Drug Safety Monitoring Boards 339 Experimental designs 31317
DSM-IV 177 Experimental studies 31314
Expert Working Groups (EWGs) 24
Edit Check Specification (ECS) 113
demography 117 Face validity 318
document 113, 117 FAX-based systems 330
finalisation process Feedback 105
for in-house studies 114 Field monitoring guidelines 118
for studies contracted to Figures 169
CRSs 115 audits 1334
request for amendment 116 Food and Drug Administration
team 113 (FDA) 378, 160, 249, 310, 3312
Edit checks Future of clinical data
defining 11318 management 1819
implementing 114
timelines 118 Good Automated Laboratory Practice
Efficacy topics, ICH 45 (GALP) 208, 249
Electronic data transfer 156 Good Automated Manufacturing
Electronic diaries 84 Practice (GAMP) 249
Electronic document management Good Clinical Practice (GCP) 6, 7, 123,
systems 239 208, 250
Electronic format CDM requirement
Biologic Licence Application Consolidated Guideline 2931
(BLA) 41 European 253
CRFs 42, 331, 333 Harmonised Tripartite Guideline
CRTs 42 for 21
Establishment Licence Application ICH 2534
(ELA) 41 regulations 252
NDAs 41 Good Laboratory Practice (GLP) 208,
Product Licence Application 250
(PLA) 41 Good Manufacturing Practice
regulatory submission (GMP) 249, 250
SEQ 0231 JOB WIL8280-400-004 PAGE-0351 IMPORT
REVISED 05NOV99 AT 13:45 BY IG DEPTH: 58.01 PICAS WIDTH 40 PICAS

INDEX 351
Good Manufacturing Practice (GMP) security 3334
regulations Intranets 341
Graphs 169 Investigator site audits 12730
IRIS Clinical 2445
Handover meeting 134 ISO 9000 1378, 208
Harmonised Tripartite Guideline for ISO 90003 208
Good Clinical Practice 21 ISO 9001 137
Health Maintenance Organisations
(HMOs) 273, 310, 340 J-ART 181, 189
Health Management Organisations
(HMOs) 340 Key variables, audit 132
Homeworking 87
HTML 334 Laboratory data 97, 165, 169
Laboratory information systems
ICH 1, 2146, 1778, 311 (LIMs) 217
administrative steps 245 Large simple trials (LST) 317
conferences 223 Listings, audits 1334
efficacy topics 45 LOINC 177
future 24
guidelines 2642 Maintenance and Support Services
history 22 Organisation (MSSO) 198200
multidisciplinary topics 46 Medcaid 311
new rules/guidelines 3642 MedDRA 11, 32, 177, 187204, 336
organisation 23 background and development
quality topics 46 1879
recommendations 43 data entry 1945
safety topics 44 data retrieval 1958
Secretariat 234 haemorrhage special search
Steering Committee 234 category 198
topics and guide lines 446 implementation 2001
Image character recognition (ICR) 4 maintenance framework 199
Implementation organ classes 191
and planning 56, 89107 scope and utility 18990
control 1067 strengths and weaknesses 2014
measures 1056 structure 1904
process Medical Dictionary for Drug Regulatory
review 1045 Activities. See MedDRA
satellite 90 Medical records, direct access 86
Incentives 106 Medical terminologies 181204
Information exchange 101 Medicare 311
Institutional Review Board (IRB) 320 Medications 165
Intelligent character recognition Metrics 1056
(ICR) 81 error 135
Interactive Voice Response (IVR) 161 reporting 146
International Classification of Diseases Microsoft Project 102
(ICD) 1847 Missing data 118, 212
International Classification of Diseases Missing values
(ICD) oncology 177 and codes 2201
International Conference on reporting 222
Harmonisation. See ICH Monitors 12930
Internet 333, 341 Motivation 106
remote data entry via 856 Multicentre clinical trials 119
SEQ 0232 JOB WIL8280-400-004 PAGE-0352 IMPORT
REVISED 05NOV99 AT 13:45 BY IG DEPTH: 58.01 PICAS WIDTH 40 PICAS

352 INDEX

National Institute of Health (NIH) 338 PROC FREQ 171


Negative numbers 221 PROC UNIVARIATE 171
New Drug Applications (NDAs) 161 Process
electronic format 41 audits 138
Normalised database design 2267 enhancement 327
flow chart 1446
Observational studies 314, 316 review 335
Optical character recognition Product development timelines 2723
(OCR) 4, 81, 99, 244, 330 Product Licence Application (PLA),
Optical mark recognition (OMR) 80, electronic format 41
330 Project
Oracle Clinical Version 3 2378 completion 95
overview 93
PAREXEL 245 Prospective studies 316, 319
Patient identifiers, Protocol 1289
inconsistencies 21417
Patient initials 214 QOST database 312
Patient Synopsis 167, 168, 170 Quality assurance group 1257, 1356
Performance personnel training 127, 129
definition 144 Quality assurance/quality control (QA/
improvements 1356 QC) 78, 32, 100, 110, 257, 261
Performance measures 89, 14357 audits 132, 133
categories 14653 CDM 11920
key milestones 1556 clinical data management 12341,
setting the baseline 1535 13940
Pharmaceutical Manufacturers data presentation 171
Association 187 definition 1245
Pharmacoeconomics 1718, 31719 embedding 327
data management 30810 software development 2623
data sourcing summary data 169
study validity 31719 Quality of Life questionnaires 330
Pharmacoepidemiology 317 Quality standards, Contract Research
Planning 90104 Organisations (CROs) 300
aim Quality system 1367
and implementation 56, 89107 Quality topics, ICH 46
see also implementation Queries 100
checklist for establishing
requirements 937 Randomisation 96
location 102 Randomised controlled trials
process 98100 (RCT) 319
requirements 923 Raw data, presentation 1667, 170
resource requirements 1024 Re-engineering 1516, 27191
scope 94 barriers to progress 2812
specification 912 baselining the current situation
staff opportunities 1034 281
systems 1002 communication 290
timelines 94, 978 definition 2756
Plots 169 developing and prioritising required
Pre-entry data review 145 changes 278
Pre-initiation study activities 320 diagnostic stage 27983
Prescription-Event-Monitoring establishing opportunities 2823
(PEM) 310 formal methods 289
SEQ 0309 JOB WIL8280-400-005 PAGE-0353 INDEX 347-354
REVISED 11NOV99 AT 15:23 BY TF DEPTH: 58.01 PICAS WIDTH 40 PICAS

INDEX 353
getting right, first time 2769 SQL (Structured Query
implementation 279, 28890 Language) 163, 164, 244
managing the transition/ Standard operating procedures
implementation 288 (SOPs) 5, 6, 95, 100, 120, 2656
mobilisation 280 Standards for expedited
need for 2714 reporting 312
presenting solutions to steering Statistical analysis/modeling 169
committee 2878 Status reports 96, 1479
prioritising opportunities Summary data
283 quality assurance 169
project failure/success 275 to identify outliers 171
quick wins 283 Supplemental NDA (SNDA) 161
solution development Surveys 314
approach 2857 System development life cycle model
plan 283 (SDLC) 14, 260
procedure 2849 documentation 262
workshops 286 Systemised Nomenclature of Medicine
targets 2768 (SNOMED) 177
team structure 278, 2845, 2889 Systems validation 1314
time improvement 274
Registration process 338 Tables, audits 1334
Regulations, enforcing 327, 3389 Technology in data management
Regulatory authorities 160 32734
inspections 136 Telecommuting 343
Relational database management Term coding 146
systems 162 Testing, computerised systems 2612
Remote data entry (RDE) 4, 824, Total quality management (TQM) 137
2389 Training
Report audits 1345 clinical data management 1356
Reporting, definitions and site personnel 129
standards 312 Treatment Emergent Signs and
Resource graph 103 Symptoms 165
Resource expansion 328, 3424
Retrospective studies 316 US Agency for Health Care Policy and
Research (AHCPR) 311
Safety
data 274, 31012 V model 260, 262
studies 315 Validation 102
topics, ICH 44 built-in system 2512
trials 308 computer systems 250, 254,
SASASSIST statements 163 261
Serious adverse events (SAE) 96, database, case study 2637
100 definitions 2501
definition 32 documentation 261, 2689
Site Management Organisations plan(ning) 2557, 25763
(SMOs) 273, 336 policy 2557
Smart cards 87 see also Data validation
Software development, quality Validation team 2578
assurance 2623 responsibilities 25860
Software validation 24970 Validity of studies 31719
Source data verification (SDV) 6, 111, Verification, computerised
118, 129 systems 2601
SEQ 0234 JOB WIL8280-400-004 PAGE-0354 IMPORT
REVISED 05NOV99 AT 13:45 BY IG DEPTH: 58.01 PICAS WIDTH 40 PICAS

354 INDEX

Vital signs by treatment group 176 World Health Organisation Adverse


Reaction Terminology. See WHO-
WHO-ART 132, 1802, 188, 189, 202 ART
Workflow systems table 246 World Wide Web (WWW) 85

Index compiled by Geoffrey C. Jones

Вам также может понравиться